Free Oestradiol and Breast Cancer Risk
Author Information
Author(s): P.F. Bruning, J.M.G. Bonfrer, A.A.M. Hart
Primary Institution: The Netherlands Cancer Institute
Hypothesis
Is the percentage of non-protein-bound oestradiol (free E2) elevated in breast cancer patients compared to controls?
Conclusion
The study found no significant difference in free E2 percentage between premenopausal women at risk for breast cancer and matched controls, but postmenopausal breast cancer patients had a higher total serum E2 concentration.
Supporting Evidence
- The study confirmed a strong inverse correlation between free E2 percentage and sex hormone binding globulin.
- Postmenopausal breast cancer patients had significantly higher total serum E2 concentrations compared to matched controls.
- No significant differences in free E2 percentage were found among premenopausal groups.
Takeaway
The study looked at hormone levels in women and found that having more free oestradiol doesn't seem to be linked to breast cancer risk in younger women, but older women with breast cancer had higher total hormone levels.
Methodology
The study measured free oestradiol and sex hormone binding globulin in plasma and serum samples from premenopausal and postmenopausal women with breast cancer and matched controls.
Limitations
The study may not account for all factors influencing hormone levels, and the sample size for some groups was relatively small.
Participant Demographics
The study included 68 premenopausal women and 38 postmenopausal women, with groups based on breast cancer risk and disease status.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website